Merck innovation fund leads $30M investment in health data management firm

Ciox Health, the Alpharetta, Ga.-based provider of the HealthSource clinical data analytics and management platform, announced on July 25 a $30 million equity investment led by Merck's Global Health Innovation Fund.

Ciox's service helps healthcare provider clients achieve data liquidity and improve health outcomes by streamlining access to patient records from other providers' systems and facilitating the coding and analysis of that data. The new funding will aid in the development of the Digital Patient Clone platform, which standardizes de-identified clinical data from disparate sources for research and development.

Merck's innovation fund invests in emerging digital health technology companies. Its most recent contribution will enable Ciox to partner with other companies in the fund's oncology-focused portfolio, according to managing director David Rubin, PhD, and therefore advance clinical research and the discovery of new treatments.

More articles on data analytics:
Analytics startup Health Catalyst raises IPO to $172M
Healthcare software company Phreesia goes public: 3 things to know
Atrium Health deploys automation, data analytics for medication management

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Top 40 Articles from the Past 6 Months